227 related articles for article (PubMed ID: 19514975)
1. Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides.
Ishihara T; Goto M; Kodera K; Kanazawa H; Murakami Y; Mizushima Y; Higaki M
Drug Deliv; 2009 Apr; 16(3):153-9. PubMed ID: 19514975
[TBL] [Abstract][Full Text] [Related]
2. Cargo delivery kinetics of cell-penetrating peptides.
Hällbrink M; Florén A; Elmquist A; Pooga M; Bartfai T; Langel U
Biochim Biophys Acta; 2001 Dec; 1515(2):101-9. PubMed ID: 11718666
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
4. Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.
Wierzbicki PM; Kogut-Wierzbicka M; Ruczynski J; Siedlecka-Kroplewska K; Kaszubowska L; Rybarczyk A; Alenowicz M; Rekowski P; Kmiec Z
Folia Histochem Cytobiol; 2014; 52(4):270-80. PubMed ID: 25511292
[TBL] [Abstract][Full Text] [Related]
5. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
El-Andaloussi S; Järver P; Johansson HJ; Langel U
Biochem J; 2007 Oct; 407(2):285-92. PubMed ID: 17627607
[TBL] [Abstract][Full Text] [Related]
6. Structural polymorphism of two CPP: an important parameter of activity.
Deshayes S; Decaffmeyer M; Brasseur R; Thomas A
Biochim Biophys Acta; 2008 May; 1778(5):1197-205. PubMed ID: 18316038
[TBL] [Abstract][Full Text] [Related]
7. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
10. Protein cargo delivery properties of cell-penetrating peptides. A comparative study.
Säälik P; Elmquist A; Hansen M; Padari K; Saar K; Viht K; Langel U; Pooga M
Bioconjug Chem; 2004; 15(6):1246-53. PubMed ID: 15546190
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptides: tools for intracellular delivery of therapeutics.
Deshayes S; Morris MC; Divita G; Heitz F
Cell Mol Life Sci; 2005 Aug; 62(16):1839-49. PubMed ID: 15968462
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure.
Bahnsen JS; Franzyk H; Sandberg-Schaal A; Nielsen HM
Biochim Biophys Acta; 2013 Feb; 1828(2):223-32. PubMed ID: 23085001
[TBL] [Abstract][Full Text] [Related]
13. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.
Lindgren ME; Hällbrink MM; Elmquist AM; Langel U
Biochem J; 2004 Jan; 377(Pt 1):69-76. PubMed ID: 12968950
[TBL] [Abstract][Full Text] [Related]
14. Protein delivery with transportans is mediated by caveolae rather than flotillin-dependent pathways.
Säälik P; Padari K; Niinep A; Lorents A; Hansen M; Jokitalo E; Langel U; Pooga M
Bioconjug Chem; 2009 May; 20(5):877-87. PubMed ID: 19348413
[TBL] [Abstract][Full Text] [Related]
15. Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.
Zhang C; Ren W; Liu Q; Tan Z; Li J; Tong C
Drug Des Devel Ther; 2019; 13():1059-1068. PubMed ID: 31040643
[TBL] [Abstract][Full Text] [Related]
16. Six-cell penetrating peptide-based fusion proteins for siRNA delivery.
Li H; Tsui T
Drug Deliv; 2015 May; 22(3):436-43. PubMed ID: 24491156
[TBL] [Abstract][Full Text] [Related]
17. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells.
Muratovska A; Eccles MR
FEBS Lett; 2004 Jan; 558(1-3):63-8. PubMed ID: 14759517
[TBL] [Abstract][Full Text] [Related]
18. Translocation properties of novel cell penetrating transportan and penetratin analogues.
Lindgren M; Gallet X; Soomets U; Hällbrink M; Bråkenhielm E; Pooga M; Brasseur R; Langel U
Bioconjug Chem; 2000; 11(5):619-26. PubMed ID: 10995204
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycans are required for translocation of amphipathic cell-penetrating peptides across membranes.
Pae J; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
Biochim Biophys Acta; 2016 Aug; 1858(8):1860-7. PubMed ID: 27117133
[TBL] [Abstract][Full Text] [Related]
20. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
